Brind.

Jorge Jimenez oversaw the US registration processes for MMJ International Holdings with the FDA and DEA.

4 reports, 2 independent Updated Jun 20

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 4
Developments: 2
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Jorge Jimenez oversaw the US registration processes for MMJ International Holdings with the FDA and DEA.

Who's involved

What this event is mainly about

FDA Jorge Jimenez

How it developed

Newest first. Tap a step to see who reported it.

Jun 20MMJ International Holdings questions the abandonment of DEA registration protocols.1 source
- finanznachrichten.de
Jun 1MMJ International Holdings product registration overseen by company representative with FDA and DEA.1 source
- pr-inside.com

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Jorge Jimenez
researcher (ORCID 0000-0001-9347-4376)

Nothing else this week.

Coverage

Newest first; wire copies grouped